Lexaria Bioscience (LEXX) Shares Outstanding (2011 - 2026)
Lexaria Bioscience (LEXX) reported Shares Outstanding of 923,680 for fiscal Q3 2026 (quarter ended May 31, 2026), unchanged from 923,680 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Shares Outstanding (2011 - 2026) Analysis & Trends
Dating back to fiscal Q3 2011, Lexaria Bioscience's Shares Outstanding record includes 60 quarters.
- Shares Outstanding has a five-year compound annual growth rate of 38.0% (FY2020 to FY2025).
- By fiscal year, Shares Outstanding came in at 923,680 in FY2024 (+109.5%), 440,938 in FY2023 (+12.4%), 392,350 in FY2022 (+34.0%) and 292,763 in FY2021 (+58.4%).
- Year over year, Shares Outstanding gained in three of the last eight quarters, with growth averaging 23.9%.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 0.0% in fiscal Q3 2025 to 115.1% in fiscal Q3 2024.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at 923,680 (Q2 2026), 923,680 (Q1 2026) and 923,680 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | 923,680.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 923,680.00 |
| Feb 28, 2026 | 923,680.00 |
| Nov 30, 2025 | 923,680.00 |
| Aug 31, 2025 | 923,680.00 |
| May 31, 2025 | 923,680.00 |
| Feb 28, 2025 | 923,680.00 |
| Nov 30, 2024 | 923,680.00 |
| Aug 31, 2024 | 923,680.00 |
| May 31, 2024 | 923,680.00 |
| Feb 29, 2024 | 717,676.00 |
| Nov 30, 2023 | 603,435.00 |
| Aug 31, 2023 | 440,938.00 |
| May 31, 2023 | 429,400.00 |
| Feb 28, 2023 | 396,733.00 |
| Nov 30, 2022 | 396,733.00 |
| Aug 31, 2022 | 392,350.00 |
| May 31, 2022 | 396,733.00 |
| Feb 28, 2022 | 394,075.00 |
| Nov 30, 2021 | 381,780.00 |
| Aug 31, 2021 | 292,763.00 |
API Access
Lexaria Bioscience Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();